Major US medical organizations including ACOG, The Menopause Society, and NASEM have concluded that compounded bioidentical hormone therapy claims of superior safety or effectiveness over FDA-approved hormone therapy are not substantiated by evidence from well-designed clinical studies, and that FDA-approved hormone therapy products are generally recommended over compounded alternatives when an FDA-approved formulation appropriate to the patient is available
Batch normalization: accelerating deep network training by reducing internal covariate shift
TrimRx provides physician oversight, dose titration based on tolerability and response, and access to licensed compounding pharmacies as part of the personalized treatment plan
Out-of-pocket costs when covered by Blue Cross Blue Shield is usually anywhere from $7 to $11, making it an extremely enticing prescription to get covered (since when not covered and prescribed, can cost over $1,000 or usually suggested drug price of $935.77)
For patients with neuropathy, that last part is criticalit's not just reducing pain signals, it's actually helping nerves regenerate
